GlaxoSmithKline Consumer Healthcare [NYSE: GSK] announces that alli?, the only FDA-approved over-the-counter weight loss product will be on shelves of pharmacies, grocery stores and mass merchandisers nationwide later this week.
alli is designed to be a partner for overweight adults willing to change how they eat and lose weight gradually. Adding alli to diet and exercise can help people lose 50 per cent more weight than with dieting alone.
alli is being supported by an unprecedented multicultural and bilingual educational effort, making it more than just a pill but a comprehensive weight loss program. With alli, people will have access to an individualized online action plan with a year?s worth of lessons included in each alli purchase, at www.myalli.com.
?alli is not for people looking for miracle pills and overnight results. It offers consumers a proven, safe, over-the-counter option to help them lose weight gradually,? says Steven L. Burton, vice president, Weight Control, GlaxoSmithKline Consumer Healthcare. ?One of the most rewarding parts of being involved with the alli revolution is the opportunity to have a real impact on the health and lives of people all across this country. We recognize people need help to lose weight and that is why we are so excited that alli is now available to provide adults with the support they need.?